Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Racial differences in fibrosis progression after HCV-related liver transplantation.

Layden JE, Cotler S, Brown KA, Lucey MR, Te HS, Eswaran S, Fimmel C, Layden TJ, Clark NM.

Transplantation. 2012 Jul 27;94(2):178-84. doi: 10.1097/TP.0b013e318253f7fa.

2.

Impact of donor and recipient race on survival after hepatitis C-related liver transplantation.

Layden JE, Cotler SJ, Grim SA, Fischer MJ, Lucey MR, Clark NM.

Transplantation. 2012 Feb 27;93(4):444-9. doi: 10.1097/TP.0b013e3182406a94.

3.

The effect of donor race on the survival of Black Americans undergoing liver transplantation for chronic hepatitis C.

Pang PS, Kamal A, Glenn JS.

Liver Transpl. 2009 Sep;15(9):1126-32. doi: 10.1002/lt.21835.

4.

Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts.

Khapra AP, Agarwal K, Fiel MI, Kontorinis N, Hossain S, Emre S, Schiano TD.

Liver Transpl. 2006 Oct;12(10):1496-503.

5.
6.

Effects of ethnicity and socioeconomic status on survival and severity of fibrosis in liver transplant recipients with hepatitis C virus.

Verna EC, Valadao R, Farrand E, Pichardo EM, Lai JC, Terrault NA, Brown RS Jr.

Liver Transpl. 2012 Apr;18(4):461-7. doi: 10.1002/lt.23376.

7.

Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study.

Belli LS, Burroughs AK, Burra P, Alberti AB, Samonakis D, Cammà C, De Carlis L, Minola E, Quaglia A, Zavaglia C, Vangeli M, Patch D, Dhillon A, Cillo U, Guido M, Fagiuoli S, Giacomoni A, Slim OA, Airoldi A, Boninsegna S, Davidson BR, Rolles K, Pinzello G.

Liver Transpl. 2007 May;13(5):733-40.

8.

A 7-gene signature of the recipient predicts the progression of fibrosis after liver transplantation for hepatitis C virus infection.

do O NT, Eurich D, Schmitz P, Schmeding M, Heidenhain C, Bahra M, Trautwein C, Neuhaus P, Neumann UP, Wasmuth HE.

Liver Transpl. 2012 Mar;18(3):298-304. doi: 10.1002/lt.22475.

9.

Recurrence of hepatitis C virus (genotype 4) infection after living-donor liver transplant in Egyptian patients.

Yosry A, Abdel-Rahman M, Esmat G, El-Serafy M, Omar A, Doss W, Zayed N, Said M, Ismail T, Hosny A, Marawan E, El-Malt O, Kamel RR, Hatata Y, El-Taweel A, Ghali A, Sabri H, Kamel S, El-Gabaly H.

Exp Clin Transplant. 2009 Sep;7(3):157-63.

10.

Long-term outcome of hepatitis C infection after liver transplantation.

Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, Maertens G, Williams R.

N Engl J Med. 1996 Mar 28;334(13):815-20.

11.

Hepatitis C recurrence and fibrosis progression are not increased after living donor liver transplantation: a single-center study of 289 patients.

Schmeding M, Neumann UP, Puhl G, Bahra M, Neuhaus R, Neuhaus P.

Liver Transpl. 2007 May;13(5):687-92.

12.

Donor-recipient race mismatch and graft survival after pediatric heart transplantation.

Kanter KR, Berg AM, Mahle WT, Vincent RN, Kilgo PD, Kogon BE, Kirshbom PM.

Ann Thorac Surg. 2009 Jan;87(1):204-9; discussion 209-10. doi: 10.1016/j.athoracsur.2008.09.074.

PMID:
19101298
13.

Predictors of graft and patient survival in hepatitis C virus (HCV) recipients: model to predict HCV cirrhosis after liver transplantation.

Iacob S, Cicinnati VR, Hilgard P, Iacob RA, Gheorghe LS, Popescu I, Frilling A, Malago M, Gerken G, Broelsch CE, Beckebaum S.

Transplantation. 2007 Jul 15;84(1):56-63.

PMID:
17627238
14.

Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C.

Rayhill SC, Wu YM, Katz DA, Voigt MD, Labrecque DR, Kirby PA, Mitros FA, Kalil RS, Miller RA, Stolpen AH, Schmidt WN.

Transplantation. 2007 Aug 15;84(3):331-9.

PMID:
17700157
15.

Donor PNPLA3 rs738409 genotype affects fibrosis progression in liver transplantation for hepatitis C.

Dunn W, O'Neil M, Zhao J, Wu CH, Roberts B, Chakraborty S, Sherman C, Weaver B, Taylor R, Olson J, Olyaee M, Gilroy R, Schmitt T, Wan YJ, Weinman SA.

Hepatology. 2014 Feb;59(2):453-60. doi: 10.1002/hep.26758. Epub 2013 Dec 23.

PMID:
24123231
16.

Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C.

Machicao VI, Bonatti H, Krishna M, Aqel BA, Lukens FJ, Nguyen JH, Rosser BG, Satyanarayana R, Grewal HP, Hewitt WR, Harnois DM, Crook JE, Steers JL, Dickson RC.

Transplantation. 2004 Jan 15;77(1):84-92.

PMID:
14724440
17.

Independent effect of black recipient race on short-term outcomes after liver transplantation.

Quillin RC 3rd, Wilson GC, Wima K, Hanseman DJ, Sutton JM, Shaw JJ, Cuffy MC, Woodle ES, Paquette I, Abbott DE, Shah SA.

Surgery. 2015 Apr;157(4):774-84. doi: 10.1016/j.surg.2014.10.018. Epub 2015 Feb 7.

PMID:
25666335
18.

Clinical outcomes of living donor liver transplantation for hepatitis C virus (HCV)-positive patients.

Takada Y, Haga H, Ito T, Nabeshima M, Ogawa K, Kasahara M, Oike F, Ueda M, Egawa H, Tanaka K.

Transplantation. 2006 Feb 15;81(3):350-4.

PMID:
16477219
19.

Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients.

Berenguer M, Prieto M, San Juan F, Rayón JM, Martinez F, Carrasco D, Moya A, Orbis F, Mir J, Berenguer J.

Hepatology. 2002 Jul;36(1):202-10. Erratum in: Hepatology. 2003 Feb;37(2):489.

PMID:
12085366
20.

Explanted liver inflammatory grade predicts fibrosis progression in hepatitis C recurrence.

Ghabril M, Dickson RC, Krishna M, Machicao V, Aranda-Michel J, Bonatti H, Nguyen JH.

Liver Transpl. 2011 Jun;17(6):685-94. doi: 10.1002/lt.22250.

Items per page

Supplemental Content

Write to the Help Desk